Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.
MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results